| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| 09/28/2006 | US20060217425 Methods of treating cancer using PPAR-gamma antagonists |
| 09/28/2006 | US20060217424 Compounds for the inhibition of nitric oxide synthase |
| 09/28/2006 | US20060217423 Antisecretory agents; antiulcer agents |
| 09/28/2006 | US20060217422 cyclization of a 1,4-dioxaspiro[4,5]decane, by heating in solvents and treating with a base, to give a spiro[1,3-dioxolane-2,6'-1,3a,5,7,8,8a,9,9a-octahydrobenzo[f][2]benzofuran]-3'-one-9'-carboxamide, useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/28/2006 | US20060217421 Fortifier |
| 09/28/2006 | US20060217420 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 09/28/2006 | US20060217419 e.g. N-cis-{4-[4-(2-isopropoxy-phenyl)-piperidin-1-yl]-cyclohexyl}-3,4-dimethoxy-benzenesulfonamide; adrenoreceptor antagonist; benign prostatic hypertrophy and lower urinary tract symptoms |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217417 Pyridine derivatives useful as inhibitors of pkc-theta |
| 09/28/2006 | US20060217416 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents |
| 09/28/2006 | US20060217415 modulators of nicotinic and/or of the monoamine receptors such as 3-(Dibenzofuran-2-yloxy)-1-azabicyclo[2.2.2]octane, useful for the treatment of nervous system disorders, neurodegenerative diseases and drug abuse and dependence |
| 09/28/2006 | US20060217414 3-amido-nortropane derivatives; opioid receptor agonist and antigonist; analgesic, anxiolytic, antitussive agent, antidepressant; asthma, alcohol abuse |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217412 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/28/2006 | US20060217411 2-Phenyl- pyrazoloquinolin-3-ones and pyrazolo(thio)chromen-3-ones, e.g., N-[4-(6-Fluoro-3-oxo-3,5-dihydropyrazolo[4,3-c]quinolin-2-yl)-phenyl]-2-methyl-butyramide; used to treat rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis |
| 09/28/2006 | US20060217410 Pre-organized tricyclic integrase inhibitor compounds |
| 09/28/2006 | US20060217409 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 09/28/2006 | US20060217408 Preparation of cabergoline |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
| 09/28/2006 | US20060217405 Interstitial cystitis treatment |
| 09/28/2006 | US20060217404 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases |
| 09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
| 09/28/2006 | US20060217402 Biocidal compounds and their preparation |
| 09/28/2006 | US20060217401 e.g. 8-Alkyl/Aryl-4-aryl-2-N-(alkylamino)-N''-substituted-N'-cyanoguanidino-8H-pyrido[2,3-d]pyrimidin-7-one compounds; CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis |
| 09/28/2006 | US20060217399 Phenyl quinolines and their use as estrogenic agents |
| 09/28/2006 | US20060217398 Substituted pyrimidine derivatives |
| 09/28/2006 | US20060217397 Sustained release ranolazine formulations |
| 09/28/2006 | US20060217396 Benzoylguanidine salt and hydrates thereof |
| 09/28/2006 | US20060217395 Combinations of paroxetine and 4- (s) - (4-acetyl-piperazin-1-yl) -2- (r)- (4-fluoro-2-methyl- phenyl -piperidine-1-carboxylic acid [1- (r) (3,5-bis-trifluoromethyl-phenyl) -ethyl] methylamide for treatment of depression and / or anxiety |
| 09/28/2006 | US20060217394 Treatment of anhedonia |
| 09/28/2006 | US20060217393 NK-1 receptor antagonists |
| 09/28/2006 | US20060217392 Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity |
| 09/28/2006 | US20060217391 Method of treating functional bowel disorders |
| 09/28/2006 | US20060217390 Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus |
| 09/28/2006 | US20060217389 Compounds for the treatment of proliferative disorders |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217387 For therapy of central nervous system disorders |
| 09/28/2006 | US20060217386 Nutritional preparations |
| 09/28/2006 | US20060217385 Nutritional preparations |
| 09/28/2006 | US20060217384 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 09/28/2006 | US20060217383 1-/2-Substituted-1H/-2H-[1,2,3]triazolo[4,5-G]phthalazine-4,9-dione compound, process for the preparation thereof and pharmaceutical composition comprising the same |
| 09/28/2006 | US20060217382 Imidazotriazine compounds |
| 09/28/2006 | US20060217381 Tuberculosis; inhibition of protein autosplicing of intein-containing proteins; using various drugs, for example 2-methyl-4-((4-methyl-1,3,4-thiadiazol-2-yl)thio)quinoline or 1,2,3-trimethylsulfonyl-5-trifluoromethylbenzene |
| 09/28/2006 | US20060217380 protein kinase modulators such as 3-((2-amino-5-pyrimidinyl)ethynyl)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide, useful for the prophylaxis and treatment of inflammation, cancer, rheumatoid arthritis and for reducing blood flow in tumors |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217377 Quinazolines useful as modulators of ion channels |
| 09/28/2006 | US20060217376 Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 09/28/2006 | US20060217375 New compounds |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | US20060217371 Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors |
| 09/28/2006 | US20060217370 Compounds useful for the treatment and prevention of pain and screening methods therefor |
| 09/28/2006 | US20060217369 Antiproliferative agents; tyrosine kinase inhibitors; anticancer; diseases associated with signal transduction pathways operating through growth factor receptors; 4-amino-1-((4-(3-methoxyphenylamino) quinazolin-5-yl)methyl)-N-methylpiperidine-3-carboxamide |
| 09/28/2006 | US20060217368 Drug for nerve regeneration |
| 09/28/2006 | US20060217367 11-Piperazin-1-yldibenzo[b,f][1,4]thiazepine or its pharmaceutically acceptable salts; for treating anxiety, agitation, hostility, panic, eating disorders, affective symptoms, mood symptoms, negative and positive psychotic symptoms commonly associated with schizophrenia, dementia, anxiety, depression |
| 09/28/2006 | US20060217366 11-Piperazin-1-yldibenzo[b,f][1,4]thiazepine or its pharmaceutically acceptable salts; for treating anxiety, agitation, hostility, panic, eating disorders, affective symptoms, mood symptoms, negative and positive psychotic symptoms commonly associated with schizophrenia, dementia, anxiety, depression |
| 09/28/2006 | US20060217365 Method of treating mood disorders |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217363 Methods and therapeutic combinations for the treatment of hypercholesterolemia and xanthoma using sterol absorption inhibitors |
| 09/28/2006 | US20060217362 Novel compounds useful for bradykinin B1 receptor antagonism |
| 09/28/2006 | US20060217361 Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 09/28/2006 | US20060217360 Tubulysin biosynthesis gene |
| 09/28/2006 | US20060217359 Therapeutic procedures |
| 09/28/2006 | US20060217358 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 09/28/2006 | US20060217357 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal |
| 09/28/2006 | US20060217356 Nutritional supplement for lowering serum triglyceride and cholesterol levels |
| 09/28/2006 | US20060217355 Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer |
| 09/28/2006 | US20060217354 recrystallizing a crude or preliminarily purified product of vitamin D derivative from an alcohol, such as methanol |
| 09/28/2006 | US20060217353 24-sulfoximine vitamin D3 compounds |
| 09/28/2006 | US20060217352 Method for treating thrombosis |
| 09/28/2006 | US20060217351 Method for treating cardiovascular diseases |
| 09/28/2006 | US20060217350 Disodium pamidronate formulation |
| 09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 09/28/2006 | US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 09/28/2006 | US20060217347 Topical formulations of borinic acid antibiotics and their methods of use |
| 09/28/2006 | US20060217345 Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases |
| 09/28/2006 | US20060217344 Compounds for the treatment of tobacco dependence and withdrawal |
| 09/28/2006 | US20060217343 2-Polycyclic propynyl adenosine analogs having A2A agonist activity |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217340 Methods and products for treating hypertension by modulation of TRPC3 channel activity |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217323 Substituted indazole-O-glucosides |
| 09/28/2006 | US20060217322 Xanthurenic acid derivative pharmaceutical compositions and methods related thereto |
| 09/28/2006 | US20060217320 Soft gel formulations for saquinavir |
| 09/28/2006 | US20060217316 Method for the treatment of prostate cancer |
| 09/28/2006 | US20060217315 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 09/28/2006 | US20060217313 5-CNAC as oral delivery agent for parathyroid hormone fragments |
| 09/28/2006 | US20060217311 VEGF antagonist formulations |
| 09/28/2006 | US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care |
| 09/28/2006 | US20060217309 Novel cyclosporine analog formulations |
| 09/28/2006 | US20060217305 Induction of tumor cell senescence by retinoid receptor agonists and antagonists |
| 09/28/2006 | US20060217303 Compounds and Methods for Treating Seizure Disorders |
| 09/28/2006 | US20060217296 For treatment and/or prevention of loss of body weight and body fat, cachexia, stimulation of appetite, food intake, stimulation of weight gain, and/or increasing body fat mass |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/28/2006 | US20060217293 Coupling low-molecular substances to a modified polysaccharide |
| 09/28/2006 | US20060217291 Radiosensitizer |